Nutritional Status Assessment
Nutritional Status Assessment
Nutritional Status Assessment
ABSTRACT
Reliable information about the nutritional status is essential to identify potential critical nutrients and the population groups at risk of deficiency, as
well as to develop effective public health policies to counteract unfavorable nutrition patterns that contribute to morbidity and mortality. In
this review, the important role of biomarkers in the assessment of nutritional status is outlined, major strengths and limitations of established and
new biomarkers are described, and important criteria for biomarker selection and development are discussed. Indeed, biomarkers offer a
more objective assessment tool than pure dietary approaches that suffer from inadequate data reporting in particular, although biomarkers
are often only measured in subsamples because of the higher costs and proband burden they entail. However, biomarkers are subject to individual
variability and influences from other factors besides the nutrient of interest. Rapid turnover or tight control of nutrient concentrations in
blood (homeostasis) limits their sensitivity as biomarkers, as in the case of many trace elements. The existence of different forms of a micronutrient
in the body adds additional complexity. Functional biomarkers, such as enzyme activities, mirror long-term status better but are subject to
confounding factors, and some are influenced by several micronutrients, not specific for only 1, so using a combination of biomarkers is advisable.
Additionally, the applicability of a biomarker also depends on the existence of adequate reference values and cutoff points for the target
population. Therefore, a careful selection is warranted, especially when biomarkers are to be used in larger samples. Adv. Nutr. 5: 590S–598S, 2014.
590S ã2014 American Society for Nutrition. Adv. Nutr. 5: 590S–598S, 2014; doi:10.3945/an.113.005330.
592S Supplement
Downloaded from https://academic.oup.com/advances/article-abstract/5/5/590S/4565778
by USP/SIBI user
on 28 June 2018
Moreover, the composition of natural foods shows a wide group in randomized controlled intervention trials. This leaves
variability related to geographical and weather conditions, testing the effects of supplementation with a nutrient on the
cultivation techniques, and crop varieties. In prepared foods, candidate biomarker as the approach of choice (51,52). How-
differences in recipes add additional complexity (45). ever, in many cases, effects are observed in depleted but much
With regards to assessing the nutritional status of individ- less in adequately supplied individuals, reducing the value of
uals, additional difficulties arise from the fact that the refer- the biomarker to detect marginal status.
ence values for nutrient intake do not necessarily correspond The choice of biomarker is strongly influenced by the study
to one’s individual nutritional needs. In fact, most of these objectives. For large-scale nutrition surveys, factors such as
values, such as the RDA for the U.S. population, the reference cost, technical and personnel requirements, feasibility, and
nutrient intake for the UK population, and the reference participants’ burden are more important determinants than
values for nutrient intake (Zufuhrempfehlungen) of the in clinical intervention studies with smaller sample sizes.
German-speaking countries, are based on the estimated me- Measuring nutrient concentrations in blood or urine is a
dian requirement (estimated average requirement) of a given widely used method for status assessment because these sam-
collective of healthy individuals to which the equivalent of 2 ples are easy obtained. However, blood concentrations of
SDs is added. For nutrients for which requirements are not many nutrients, especially those involved in regulatory mech-
normally distributed within a population, the SD is replaced anisms such as calcium, zinc, and retinol, are maintained
by a CV of 20–30%. In this way, the requirements of 97.5% of within narrow ranges regardless of body stores (53,54).
the population are covered, but an inadequate supply would Changes in blood concentrations of such nutrients only occur
be expected in 2.5% of the population (2,46,47). In this in progressed/severe deficiency states. In other cases, like for
case, but also at population level, more accurate results re- carotenoids, they can vary markedly because of a short half-
quire the use of biochemical markers of nutrient status. life and depending on recent intake (55). Moreover, conditions
such as acute infections or stress can influence serum concen-
Nutritional biomarkers: criteria for development and trations of some nutrients, such as zinc (56). Concentrations
selection. A nutritional biomarker is a biochemical indica- in other tissues, such as cell membranes, fat tissue, or bone,
tor of intake and/or status of a given nutrient or food com- fluctuate less, which gives a better view of long-term supply.
ponent. Status markers are direct markers of past exposure. Unfortunately, some of these samples are difficult to obtain.
In turn, functional markers reflect an effect of a nutrient or For the assessment of the status of long-chain PUFAs, the con-
its absence. As such, some of them can also act as interme- centration in membrane phospholipids measured in erythro-
diate markers for future disease risk (36,37). cytes or whole blood were identified as better biomarkers of
The development of a nutritional biomarker for a specific long-term exposure than plasma concentrations (57,58).
nutrient is in most cases based on what is known about the Moreover, suboptimal nutrient intake over a longer time
chemistry, absorption, distribution in the body, and metab- can affect specific physiologic functions, such as activities of
olism of the latter. enzymes with nutrients as cofactors, which can serve as
With recent advances in metabolomic techniques enabling functional biomarkers (49).
the simultaneous measurement of several analytes and large An overview of plasma concentrations and examples of
sample amounts, the search for biomarkers can also follow a functional biomarkers for some micronutrients is given in
more inductive approach in that metabolites found in the sam- Table 1.
ple are examined for their suitability as biomarkers (48).
The search for nutritional biomarkers requires well-controlled Biomarkers complement dietary assessment. In the Aus-
dietary intervention designs to minimize potential confounding trian Nutrition Report 2012 (59), activity of erythrocyte gluta-
factors and a careful validation of the candidate markers, espe- mic oxaloacetic transaminase, a functional marker of vitamin
cially regarding dose–response effects and their specificity, sensi- B-6 status, better reflected the intake of this nutrient than the
tivity, and suitability for various population subgroups (37). plasma concentration of pyridoxal phosphate, especially in
However, although biomarkers allow a more objective as- adults younger than 65 y. Plasma concentrations were adequate
sessment of nutrient status, the fact that the effects of dietary in >80% of adults and elderly and 99% of children, whereas in-
compounds on body functions are generally more subtle and take was below the recommended amounts in 18% of male and
less clearly delimitable than those seen after drug administra- 32% of female children, ~40% of adults, and approximately
tion makes them less efficient than biomarkers used in drug half of the elderly. In turn, erythrocyte glutamic oxaloacetic
trials. For instance, marginal deficiency states are generally transaminase activity suggested a deficient status in ~40%
not associated with manifest clinical symptoms, which makes of children and adult men, 55% of adult women, and 22%
their detection much more challenging than that of a single and 26% of elderly women and men, respectively.
drug effect. Indeed, the absence of severe deficiency signs The importance of biomarkers for status assessment was
does not exclude detrimental effects on the body, underscoring also seen for folate in the Austrian Nutrition Report 2012, a
the importance of early diagnosis (49,50). This hierarchy of ef- national nutrition survey conducted in a representative sample
fects of nutrient deficiency on the body is depicted in Figure 1. of 1002 individuals from various age groups (59). Although
Moreover, testing biomarkers for essential nutrients limits 94–100% of the participants across all age groups did not
the possibilities to include a nonexposed human control reach the then-recommended intake value of 400 mg/d,
70–80% of children and adults and almost 70% of the elderly and the risk of cardiovascular and other metabolic and auto-
had adequate plasma concentrations of this vitamin. Homo- immune diseases, benefits from higher concentrations in the
cysteine concentrations were higher in individuals with lower healthy general population were not shown unequivocally
folic acid plasma concentrations, confirming the suitability of (61,62). Furthermore, serum concentrations below the ref-
this metabolite as a biomarker for folate, although it is also erence range are not necessarily associated with deficiency.
associated with vitamin B-12 and vitamin B-6 (59). Thus, African Americans have on average lower serum
Comparable discrepancies between the status assessed 25(OH)D3 concentrations than their white counterparts,
from dietary intake and the biochemical status were also re- but the prevalence of osteoporosis and the occurrence of fra-
ported from other countries. Thus, although according to the gility fractures are also lower (63). To define optimal ranges
NHANES the majority of the U.S. population does not meet for serum 25(OH)D3 concentrations for different popula-
the estimated average requirement, the biochemical status tion groups, additional randomized controlled trials are
based on serum a-tocopherol was deficient in <1% in the warranted, taking into account ethnic differences and the in-
Second National Report on Biochemical Indicators of Diet fluence of age-, gender-, and disease-related aspects (61,62).
and Nutrition in the U.S. Population 2012 (60). As discussed Correct reference ranges and validated sensitive and spe-
above, a possible explanation lies in the selective underre- cific biomarkers also reduce the risk of measurement errors
porting of fat-rich food that is the major source of vitamin E. and misclassification that can negatively influence the inter-
pretation of a study outcome.
The Importance of Reference Ranges The influence of genetic variability and differences between
The correct interpretation of biomarkers requires well- nutrient forms. Not only in the case of vitamin D are bio-
defined reference values for the respective marker. However, markers of nutritional status influenced by an individual’s
in many cases, there is still a lack of consensus on the normal genetic makeup. Genes involved in the absorption and me-
range in healthy adequately supplied individuals. An example tabolism of nutrients and other food components determine
that received much attention recently is vitamin D. Although the concentrations of these compounds in various body tis-
serum concentration of 25-hydroxy vitamin D3 [25(OH)D3] sues. This was shown for single nucleotide polymorphisms
is widely acknowledged as a valid biomarker for vitamin D in genes involved in the absorption, transport, and metabo-
status that reflects dietary intake and endogenous synthesis, lism of fat-soluble vitamins, such as genes for apoA, apoB,
the optimal range of this variable is still the matter of debate. and apoE, as well as lipoprotein lipase, scavenger-receptor class
Cutoffs for deficiency are generally set between 25 and B type I (SR-BI), and carotene oxygenases that were related to
50 nmol/L (10–20 ng/dL) based on the effects on calcium and plasma concentrations of a- and g-tocopherol, a- and b-
phosphate metabolism and bone health. However, with the carotene, lycopene, and b-cryptoxanthin and the response
emergence of new physiologic roles for vitamin D, questions to their dietary intake (64,65).
about the optimal range arose. Although some evidence exists Genetic variations also cause differences in nutrient re-
for associations between 25(OH)D3 serum concentrations quirements, such as the C677T polymorphism in the methylene
594S Supplement
Downloaded from https://academic.oup.com/advances/article-abstract/5/5/590S/4565778
by USP/SIBI user
on 28 June 2018
TABLE 1 Overview of the plasma concentrations and examples of functional biomarkers (nonexhaustive) for selected micronutrients1
Plasma concentration cutoffs
for status assessment Functional biomarkers Clinical signs of deficiency
Vitamin A
.1.05 μmol/L, normal Retinol-binding protein Night blindness, xerophthalmia, anemia
,0.7 μmol/L, markedly deficient
Vitamin D [as 25(OH)D3]
.50 nmol/L, desirable Alkaline phosphatase activity; Decline of bone density, rickets in children, osteomalacia in
,25 nmol/L, deficient serum osteocalcin adults, disturbed immune function
Vitamin B-6 (as pyridoxal phosphate)
.30 nmol/L, normal a-EGOT activity Rare; neurologic symptoms, seborrhea, dermatitis, eczema,
,20 nmol/L, deficient cheilosis, anemia (microcytic, hypochromic)
Folate (as folic acid)
$13.4 nmol/L, normal HCys, urinary excretion of FIGLU Anemia (macrocytic, hyperchromic), cheilosis, glossitis,
,6.8 nmol/L, markedly deficient neurologic symptoms in elderly, higher risk of cardiovas-
In erythrocytes: cular diseases (through HCys)
$356 nmol/L, normal
,317 nmol/L, deficient
Vitamin B-12
$147 pmol/L, normal HCys, methylmalonic acid Anemia (macrocytic, hyperchromic), neurologic symptoms
,110 nmol/L, markedly deficient
Calcium
Excretion in urine, 2.5–6.0 mmol/d, normal Excretion of hydroxyproline in urine Decline of bone density, osteoporosis, rickets in children,
osteomalacia in adults
Iron
Ferritin $15 μg/L, normal Hemoglobin, hematocrit, total iron Anemia (microcytic, hypochromic)
$12 μg/L (in children aged ,5 y), normal binding capacity
Zinc
Adults Activity of zinc superoxide dismutase, Growth retardation in children, disturbed immune function
13–19 μmol/L, normal zinc binding capacity in thalassemia (especially cellular), reduced glucose tolerance, skin
,11.5 μmol/L, deficient lesions, impaired wound healing
Children
,10 y: ,9.9 μmol/L, deficient
Pregnant women
Trimester 1: ,8.6 μmol/L, deficient
Trimester 2: 7.6 μmol/L, deficient
1
Based on data from references 49,79. α-EGOT, erythrocyte α-glutamate oxaloacetate transferase; FIGLE, formiminoglutamic acid; HCy, homocysteine.
tetrahydrofolate reductase (MTHFR) gene, resulting in a less equivalents that comprise all vitamers as far as these are
active enzyme and an association with a higher risk of neural measured. With regards to the special properties of non-
tube defects and cardiovascular disease (66). Because MTHFR a-tocopherol forms, a better differentiation seems advisable.
provides 5-methyl tetrahydrofolate as a methyl donor for the
reconversion of homocysteine to methionine, the lower activ- New nutritional biomarkers: the potential role of immune
ity of the mutant MTHFR can be compensated by higher fo- functions and gene expression. Advances in molecular bi-
late intake (66). ology extended our insights in the physiology of nutrients,
Another aspect to consider is the fact that nutrients occur thus offering new potential biomarkers of their status. In-
in different forms in food and in the body. These isomers deed, vitamins and minerals, but also FAs, especially PUFAs,
generally differ in their biologic activity, calling for conver- and amino acids can influence gene expression and cell pro-
sion factors to define equivalents. Although a single form liferation, and this has a particular impact on highly prolifer-
may reflect total body stores adequately [such as 25(OH) ating cells such as those of the immune system. Thus, it was
D3 for vitamin D], isoforms can differ in their effects. An reported that deficiency of trace elements, especially zinc and
example of this is vitamin E, because special functions of copper, was associated with reduced secretion of mediators,
g-tocopherol and the tocotrienols are emerging that are such as IL-2, IL-1b, and TNF-a, after mitogenic stimulation.
not observed with a-tocopherol, the major bioactive form Notably, a decrease of IL-2 secretion was already observed af-
(67). In some studies, g-tocopherol proved to be a more po- ter marginal copper deficiency (56,69). In turn, supplemen-
tent anticancerogenic agent than a-tocopherol, an effect that tation with zinc increased the stimulated secretion of IL-1b,
may be due to its better ability to scavenge reactive nitrogen IFN-g, and TNF-a (70). However, although cytokines and other
species. Being more hydrophilic than a-tocopherol, it exerts immune function markers may be sensitive markers of nutrient
its antioxidant effects in a complimentary way in other cell deficiency, they are rather unspecific (70).
compartments (67). Although studies are less abundant than In the case of zinc, recent studies identified some potential
for a-tocopherol, tocotrienols also showed positive effects markers, such as changes in zinc absorption and expression
on health and the prevention of diseases (68). So far, vitamin of zinc transporters and the storage protein metallothionein
E status is generally assessed on the basis of a-tocopherol (70,71). It was reported that zinc absorption is more influenced
596S Supplement
Downloaded from https://academic.oup.com/advances/article-abstract/5/5/590S/4565778
by USP/SIBI user
on 28 June 2018
10. World Health Organization. Preventing and managing the global epi- intake biomarkers to evaluate the extent of dietary misreporting in a
demic of obesity. Report of the World Health Organization Consulta- large sample of adults: the OPEN study. Am J Epidemiol 2003;158:
tion on Obesity. Geneva: World Health Organization; 1997. 1–13.
11. National Institutes of Health. The practical guide: identification, evalu- 32. Lissner L, Troiano RP, Midthune D, Heitmann BL, Kipnis V, Subar AF,
ation and treatment of overweight and obesity in adults. Bethesda Potischman N. OPEN about obesity: recovery biomarkers, dietary re-
(MD): National Institutes of Health; 2000. porting errors and BMI. Int J Obes (Lond) 2007;31:956–61.
12. Han TS, van Leer EM, Seidell JC, Lean MEJ. Waist circumference action 33. Ngo J, Engelen A, Molag M, Roesle J, García-Segovia P, Serra-Majem L.
levels in the identification of cardiovascular risk factors: prevalence A review of the use of information and communication technologies
study in a random sample. BMJ 1995;311:1401–5. for dietary assessment. Br J Nutr 2009;101:S102–12.
13. Ross R, Berentzen T, Bradshaw AJ, Janssen I, Kahn HS, Katzmarzyk PT, 34. Goldberg GR, Black AE, Jebb SA, Cole TJ, Murgatroyd PR, Coward
Kuk JL, Seidell JC, Snijder MB, Sørensen TIA, et al. Does the relation- WA, Prentice AM.Critical evaluation of energy intake data using funda-
ship between waist circumference, morbidity and mortality depend on mental principles of energy physiology: 1. derivation of cut-off limits
measurement protocol for waist circumference? Obes Rev 2008;9:312–25. to identify under-recording. Eur J Clin Nutr 1991;45:569–81.
14. WHO Expert Consultation. Appropriate body-mass index for Asian 35. Cade J, Thompson R, Burley V, Warm D. Development, validation and
populations and its implications for policy and intervention strategies. utilisation of food-frequency questionnaires—a review. Public Health
Lancet 2004;363:157–63. Nutr 2002;5:567–87.
15. Cameron AJ, Sicree RA, Zimmet PZ, Alberti KG, Tonkin AM, Balkau B, 36. Kaaks R, Ferrari P, Ciampi A, Plummer M, Riboli E. Uses and limita-
Tuomilehto J, Chitson P, Shaw JE. Cut-points for waist circumference in tions of statistical accounting for random error correlations, in the val-
Europids and South Asians. Obesity (Silver Spring) 2010;18:2039–46. idation of dietary questionnaire assessments. Public Health Nutr 2002;
16. Carroll JF, Chiapa AL, Rodriquez M, Phelps DR, Cardarelli KM, 5:969–76.
Vishwanatha JK, Bae S, Cardarelli R. Visceral fat, waist circumference, 37. Freisling H, Elmadfa I, Schuh W, Wagner KH. Development and vali-
and BMI: Impact of race/ethnicity. Obesity (Silver Spring) 2008;16:600–7. dation of a food frequency index using nutritional biomarkers in a
17. International Diabetes Federation. IDF consensus worldwide definition sample of middle-aged and older adults. J Hum Nutr Diet 2009;22:
of the metabolic syndrome [cited 2014 March 28]. Available from: 29–39.
http://www.idf.org/metabolic-syndrome. 38. Jenab M, Slimani N, Bictash M, Ferrari P, Bingham SA. Biomarkers in
18. De Lorenzo A, Deurenberg P, Pietrantuono M, Di Daniele N, Cervelli nutritional epidemiology: applications, needs and new horizons. Hum
V, Andreoli A. How fat is obese? Acta Diabetol 2003;40:S254–7. Genet 2009;125:507–25.
19. Marques-Vidal P, Pécoud A, Hayoz D, Paccaud F, Mooser V, Waeber G, 39. Kuhnle GGC. Nutritional biomarkers for objective dietary assessment.
Vollenweider P. Normal weight obesity: relationship with lipids, glycae- J Sci Food Agric 2012;92:1145–9.
mic status, liver enzymes and inflammation. Nutr Metab Cardiovasc 40. Livingstone MB, Black AE. Markers of the validity of reported energy
Dis 2010;20:669–75. intake. J Nutr 2003;133:895S–920S.
20. Wagner DR, Heyward VH. Techniques of body composition assess- 41. Tasevska N, Runswick SA, McTaggart A, Bingham SA. Urinary sucrose
ment: a review of laboratory and field methods. Res Q Exerc Sport and fructose as biomarkers for sugar consumption. Cancer Epidemiol
1999;70:135–49. Biomarkers Prev 2005;14:1287–94.
21. Ball SD, Altena TS. Comparison of the Bod Pod and dual energy x-ray 42. Food and Agriculture Organization of the United Nations. Interna-
absorptiometry in men. Physiol Meas 2004;25:671–8. tional Network of Food Data Systems (INFOODS) (cited 2014 March
22. Food and Agriculture Organization of the United Nations. Food bal- 28). Available from: http://www.fao.org/infoods/infoods/en/.
ance sheets. A handbook. Rome: Food and Agriculture Organization; 43. Pennington JA, Stumbo PJ, Murphy SP, McNutt SW, Eldridge AL,
2001. McCabe-Sellers BJ, Chenard CA. Food composition data: the founda-
23. Elmadfa I, editor. European Nutrition and Health Report 2009. Basel tion of dietetic practice and research. J Am Diet Assoc 2007;107:
(Switzerland): Karger; 2009. p.62. 2105–13.
24. Elmadfa I, Weichselbaum E, editors. European Nutrition and Health 44. Williamson C; EuroFIR. Synthesis report No 2: the different uses of food
Report 2004. Basel (Switzerland): Karger; 2004. p.58. composition databases EuroFIR, Norwich, United Kingdom (2006).
25. WHO Regional Office for Europe. Nutrition and Food Security Pro- 45. Pennington JAT. Applications of food composition data: data sources
gramme. Comparative analysis of food and nutrition policies in and considerations for use. J Food Compos Anal 2008;21:S3–S12.
WHO European Member States. Copenhagen: World Health Organiza- 46. German Nutrition Society, Austrian Nutrition Society, Swiss Society for
tion; 2003. Nutrition Research, Swiss Nutrition Association. Reference values for
26. Suchanek P, Poledne R, Hubacek JA. Dietary intake reports fidelity–fact nutrient intake. 1st ed., 5th corrected reprint. Frankfurt/Main (Ger-
or fiction? Neuroendocrinol Lett 2011;32:29–31. many): Umschau/Braus; 2013.
27. Goris AH, Westerterp-Plantenga MS, Westerterp KR. Undereating and 47. Department of Health. Dietary reference values for food energy and
underrecording of habitual food intake in obese men: selective under- nutrients in the United Kingdom. London: Her Majesty’s Stationary
reporting of fat intake. Am J Clin Nutr 2000;71:130–4. Office; 1991.
28. Shahar DR, Yu B, Houston DK, Kritchevsky SB, Newman AB, Sellmeyer 48. García-Cañas V, Simó C, León C, Cifuentes A. Advances in nutrige-
DE, Tylavsky FA, Lee JS, Harris TB; Health, Aging, and Body Composi- nomics research: novel and future analytical approaches to investigate
tion Study. Misreporting of energy intake in the elderly using doubly la- the biological activity of natural compounds and food functions.
beled water to measure total energy expenditure and weight change. J Pharm Biomed Anal 2010;51:290–304.
J Am Coll Nutr. 2010;29:14–24. 49. Sauberlich HE. Laboratory tests for the assessment of nutritional status.
29. Rangan A, Allman-Farinelli M, Donohoe E, Gill T. Misreporting of en- 2nd ed. Boca Raton (FL): CRC Press; 1999.
ergy intake in the 2007 Australian Children’s Survey: differences in the 50. Shenkin A. Micronutrients in health and disease. Postgrad Med J 2006;
reporting of food types between plausible, under- and over-reporters of 82:559–67.
energy intake. J Hum Nutr Diet 2013;Nov 8 (Epub ahead of print; DOI: 51. Heaney RP. Nutrients, endpoints, and the problem of proof. J Nutr
10.1111/jhn.12182). 2008;138:1591–5.
30. Poslusna K, Ruprich J, de Vries JH, Jakubikova M, van’t Veer P. Misre- 52. Blumberg J, Heaney RP, Huncharek M, Scholl T, Stampfer M, Vieth R,
porting of energy and micronutrient intake estimated by food records Weaver CM, Zeisel SH. Evidence-based criteria in the nutritional con-
and 24 hour recalls, control and adjustment methods in practice. Br J text. Nutr Rev 2010;68:478–84.
Nutr 2009;101:S73–85. 53. Panel on Micronutrients, Subcommittees on Upper Reference Levels of
31. Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, Bingham S, Nutrients and of Interpretation and Use of Dietary Reference Intakes,
Sharbaugh CO, Trabulsi J, Runswick S, Ballard-Barbash R, et al. Using and the Standing Committee on the Scientific Evaluation of Dietary
598S Supplement
Downloaded from https://academic.oup.com/advances/article-abstract/5/5/590S/4565778
by USP/SIBI user
on 28 June 2018